AzTrials
AzTrials

Post Prostatectomy IncontinenceMansprostIVNCT03494049

Veil Preserving HoLEP vs. Stanadard HoLEP

A study testing Veil sparring HoLEP and Standard HoLEP in people with Post Prostatectomy Incontinence, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly. Read more about this study

Who is it for?
Ages 50 years and older, men only
Conditions the study is for
Post Prostatectomy Incontinence
What is being tested?
Veil sparring HoLEP and Standard HoLEP
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteEgypt
Study dates
22 Apr 2016to 12 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients' age ≥50 years
  • ASA (American society of anesthesiologists) score ≤3.
  • TRUS estimated weight ≥40 grams.

Who cannot join

  • Patients who have any of the following were excluded:
  • Patient with neurological disorder which might affect bladder function as cerebrovascular stroke or Parkinson disease.
  • Active urinary tract infection.
  • Presence of bladder cancer (within the last 2 years).
  • Prostate cancer patients.
  • Patients with bleeding tendency, ongoing anticoagulants or antiplatelet medications
  • Previous prostate surgery

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Urology and nephrology center

    Al Mansurah, DK, 35516

Other trials in Egypt

About this study

Official title: Veil-preserving Versus Standard Holmium Laser Enucleation of the Prostate: Randomized Clinical Trial

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Our hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if anny would be shortened.

Read the detailed description

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients.

Many reports addressed different variables for the cause of post HoLEP urine leakage. Looking for a procedure done by a single surgeon who had tremendous experience of this procedure may enable investigators to identify precisely technical points of interest that may affect post HoLEP stress urine incontinence.

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Investigators' hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if any would be shortened.

Being tested
Veil sparring HoLEP, Standard HoLEP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Veil sparring HoLEPProcedure or surgery

    Also called early apical separation

    Early mucosal incision; lateral to the Veru and proximal to the apical bulge of the adenoma, followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch.

    Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

  • Standard HoLEPProcedure or surgery

    Holmium laser enucleation of the prostate in the standard approach described by Elhilali et al 2010

Study groups in NCT03494049
Study groupRoleWhat they receive
Veil sparring HoLEPActive comparatorEarly mucosal incision lateral to the Veru followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.
Receives: Procedure: Veil sparring HoLEP
Standard HoLEPActive comparatorStandard HoLEP TECHNIQUE as described by Elhilali et al 2010
Receives: Procedure: Standard HoLEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. urine incontinence

    one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence

    Measured: 1 month postoperative

Secondary outcomes (4)
  1. international prostate symptom score

    Symptoms core assessment, score from 0 to 35, the higher the worse the urinary symptoms

    Measured: 1 year

  2. urine flow rate

    rate of urine flow per unit time, how many milliliters of urine passed per second, above 15ml/second is normal

    Measured: 1 year

  3. urine incontinence

    one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence

    Measured: 4 months postoperative

  4. International Consultation on Incontinence Questionnaire Short-Form

    Continence core assessment, score from 0 to 21, the higher the worse the urinary continence

    Measured: one month postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2018
  2. Study start22 Apr 2016
  3. Primary completion8 Dec 2020
  4. Study completion12 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03494049
Sponsor's protocol ID
RP.19.11.49
Acronym
MansprostIV
Status last verified
Jun 2023
First submitted
31 Mar 2018
Last updated
15 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Veil sparring HoLEP and Standard HoLEP in people with Post Prostatectomy Incontinence, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

urine incontinence (time frame: 1 month postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in